Zika Virus Infections Pipeline Analysis 2018 – Focusing On Clinical Trials And Results, Drug Profiling, Patents, Collaborations, And Other Recent Developments
- Published : Mar 2020
- Report Code : KSI061611485
- Pages : 114
Offered with this report
Market Data and Estimates in Excel
2 Months of Post Sale Analyst Support
Requirement Specific Customization
Zika virus infections Pipeline Analysis 2018 – Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments.
Zika virus infections Pipeline Analysis report covers drugs of 4 companies currently in different phases of development. Zika virus infections are spread via an infected mosquito bite, Aedes aegypti and Aedes albopictus. Zika can be passed on to a foetus from a pregnant woman infected with the virus and can cause birth defects, miscarriage and stillbirth. Symptoms of the infections include fever, rash, headache, red eyes among others. There is no vaccine or medicine for zika virus infections.
The report provides Zika virus infections treatment drugs by company, phases of development including products in early discovery stage and NDA filing, molecule type, route of administration and region. The report will help to evaluate the collaboration, in-licensing and out-licensing opportunities, formulating business development strategies and tracking the activities of the key market players. Epidemiology, major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented to offer stakeholders a better understanding of the key factors affecting the overall market environment.
Various databases (for patents and Clinical Trials), studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the market.
Major industry players profiled as part of the report are Takeda Pharmaceutical Company Limited, Humabs BioMed SA, Valneva SE, Moderna Therapeutics and Emergent BioSolutions Inc. among others.
Scope:
By Company
By Phase
By Molecule Type
By Region
By Route of Administration
1. Introduction
1.1. Research Methodology
1.2. Research Scope
1.2.1. Analysis by Company
1.2.2. Analysis by Phase
1.2.3. By Molecule Type
1.2.4. By region
2. Disease Overview
2.1.1. Introduction
2.1.2. Classification
2.1.3. Symptoms
2.1.4. Causes
2.1.5. Diagnoses
2.1.6. Treatment
2.1.7. Epidemiology
3. Executive Summary
4. Market Dynamics
4.1. Drivers
4.2. Restraints
4.3. Opportunities
5. Pipeline Analysis/Outlook
5.1. Analysis by Company
5.2. Analysis by Phase
5.2.1. Phase of Development
5.2.1.1. Introduction
5.2.1.1.1. Drug Profiling
• Drug Name
• Generic Name
• Synonyms
• Company
• Collaborator
• Route of administration
• Target
• Mechanism of Action
• Technology
• Molecule type
• CAS Number
• Weight
• Chemical Formula
• IUPAC name
• ATC code
5.2.1.1.2. Strategic Developments
5.2.1.1.3. Clinical trials
5.2.1.1.4. Clinical trial results
5.2.1.1.5. Patents
5.2.1.1.6. Technology
5.2.2. Comparative Analysis for Trials by Phase (Pie, Bar graph)
5.3. By Molecule type
5.4. Analysis by Region
6. Company profiling
6.1. Emergent BioSolutions Inc.
6.1.1. Introduction
6.1.2. Financials
6.1.3. Products and Services
6.1.4. SWOT
6.2. Valneva SE
6.2.1. Introduction
6.2.2. Financials
6.2.3. Products and Services
6.2.4. SWOT
6.3. Themis Bioscience GmbH
6.3.1. Introduction
6.3.2. Financials
6.3.3. Products and Services
6.3.4. SWOT
6.4. Tychan Pte. Ltd
6.4.1. Introduction
6.4.2. Financials
6.4.3. Products and Services
6.4.4. SWOT
6.5. Takeda Pharmaceutical Company Limited
6.5.1. Introduction
6.5.2. Financials
6.5.3. Products and Services
6.5.4. SWOT
6.6. Moderna Therapeutics
6.6.1. Introduction
6.6.2. Financials
6.6.3. Products and Services
6.6.4. SWOT
6.7. Geneone Life Science
6.7.1. Introduction
6.7.2. Financials
6.7.3. Products and Services
6.7.4. SWOT
6.8. Inovio Pharmaceuticals, Inc.
6.8.1. Introduction
6.8.2. Financials
6.8.3. Products and Services
6.8.4. SWOT
6.9. PaxVax, Inc.
6.9.1. Introduction
6.9.2. Financials
6.9.3. Products and Services
6.9.4. SWOT
6.10. Humabs BioMed SA
6.10.1. Introduction
6.10.2. Financials
Valneva SE
Themis Bioscience GmbH
Tychan Pte. Ltd
Takeda Pharmaceutical Company Limited
Moderna Therapeutics
Geneone Life Science
Inovio Pharmaceuticals, Inc.
PaxVax, Inc.
Humabs BioMed SA
Related Reports
| Report Name | Published Month | Get Sample PDF |
|---|---|---|
| Bioceramics Market Size, Share & Growth: Industry Report, 2021-2026 | Aug 2021 | |
| Brazil Adhesives Market Size & Growth: Industry Report, 2023-2028 | Jun 2023 | |
| Brazil Aseptic Packaging Market Size & Share: Report, 2023 - 2028 | Jun 2023 | |
| Brazil Material Handling Market Size & Share: Report, 2023 - 2028 | Dec 2023 | |
| Brazil Flexible Packaging Market Size & Share: Report, 2022-2027 | Jun 2022 |